scholarly journals Spatiotemporal distribution of COVID-19 during the first 7 months of the epidemic in Vietnam

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Toshie Manabe ◽  
Dung Phan ◽  
Yasuhiro Nohara ◽  
Dan Kambayashi ◽  
Thang Huu Nguyen ◽  
...  
Keyword(s):  
Infectious Diseases ◽  
Phase 1 ◽  
Age Distribution ◽  
Emerging Infectious Diseases ◽  
Spatial Cluster ◽  
Spatiotemporal Distribution ◽  
Control Measures ◽  
World Health ◽  
Phase 2 ◽  
Epidemic Wave

Abstract Background Understanding the spatiotemporal distribution of emerging infectious diseases is crucial for implementation of control measures. In the first 7 months from the occurrence of COVID-19 pandemic, Vietnam has documented comparatively few cases of COVID-19. Understanding the spatiotemporal distribution of these cases may contribute to development of global countermeasures. Methods We assessed the spatiotemporal distribution of COVID-19 from 23 January to 31 July 2020 in Vietnam. Data were collected from reports of the World Health Organization, the Vietnam Ministry of Health, and related websites. Temporal distribution was assessed via the transmission classification (local or quarantined cases). Geographical distribution was assessed via the number of cases in each province along with their timelines. The most likely disease clusters with elevated incidence were assessed via calculation of the relative risk (RR). Results Among 544 observed cases of COVID-19, the median age was 35 years, 54.8% were men, and 50.9% were diagnosed during quarantine. During the observation period, there were four phases: Phase 1, COVID-19 cases occurred sporadically in January and February 2020; Phase 2, an epidemic wave occurred from the 1st week of March to the middle of April (Wave 1); Phase 3, only quarantining cases were involved; and Phase 4, a second epidemic wave began on July 25th, 2020 (Wave 2). A spatial cluster in Phase 1 was detected in Vinh Phuc Province (RR, 38.052). In Phase 2, primary spatial clusters were identified in the areas of Hanoi and Ha Nam Province (RR, 6.357). In Phase 4, a spatial cluster was detected in Da Nang, a popular coastal tourist destination (RR, 70.401). Conclusions Spatial disease clustering of COVID-19 in Vietnam was associated with large cities, tourist destinations, people’s mobility, and the occurrence of nosocomial infections. Past experiences with outbreaks of emerging infectious diseases led to quick implementation of governmental countermeasures against COVID-19 and a general acceptance of these measures by the population. The behaviors of the population and the government, as well as the country’s age distribution, may have contributed to the low incidence and small number of severe COVID-19 cases.

scholarly journals Live wildlife trade in markets - a scoping review to inform risk assessment of emerging infectious diseases

2021 ◽  
Author(s):  
Victoria J Brookes ◽  
Okta Wismandanu ◽  
Etih Sudarnika ◽  
Justin A Roby ◽  
Lynne Hayes ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Infectious Diseases ◽  
Scoping Review ◽  
Epistemic Uncertainty ◽  
Mammalian Species ◽  
Emerging Infectious Diseases ◽  
World Health Organisation ◽  
World Health ◽  
Wildlife Trade ◽  
The Impact

Wet markets are important for food security in many regions worldwide but have come under scrutiny due to their potential role in the emergence of infectious diseases. The sale of live wildlife has been highlighted as a particular risk, and the World Health Organisation has called for the banning of live, wild-caught mammalian species in markets unless risk assessment and effective regulations are in place. Following PRISMA guidelines, we conducted a global scoping review of peer-reviewed information about the sale of live, terrestrial wildlife in markets that are likely to sell fresh food, and collated data about the characteristics of such markets, activities involving live wildlife, the species sold, their purpose, and animal, human, and environmental health risks that were identified. Of the 59 peer-reviewed records within scope, only 25% (n = 14) focussed on disease risks; the rest focused on the impact of wildlife sale on conservation. Although there were some global patterns (for example, the types of markets and purpose of sale of wildlife), there was wide diversity and huge epistemic uncertainty in all aspects associated with live, terrestrial wildlife sale in markets such that the feasibility of accurate assessment of the risk of emerging infectious disease associated with live wildlife trade in markets is limited. Given the value of both wet markets and wildlife trade and the need to support food affordability and accessibility, conservation, public health, and the social and economic aspects of livelihoods of often vulnerable people, there are major information gaps that need to be addressed to develop evidence-based policy in this environment. This review identifies these gaps and provides a foundation from which information for risk assessments can be collected.

scholarly journals Emerging zoonoses in Indonesia: implication for the future

2020 ◽  
Vol 39 (3) ◽  
pp. 151
Author(s):  
Toni Wandra
Keyword(s):  
Infectious Diseases ◽  
World Health Organization ◽  
Emerging Infectious Diseases ◽  
Zoonotic Diseases ◽  
World Health ◽  
Emerging Zoonoses ◽  
The Future ◽  
Health Organization

World Health Organization (WHO) defines zoonotic diseases (zoonoses) as those diseases and infections which are naturally transmitted between vertebrate animals and humans. More than 250 zoonoses have been described, over 60% of pathogens that cause diseases in humans are zoonoses of animals, and 75% of emerging infectious diseases. Most pandemics are caused by zoonoses.

scholarly journals The role of nutrition in strengthening immune system against newly emerging viral diseases: case of SARS-CoV-2

2020 ◽  
Vol 4 (7) ◽  
pp. 240-244
Author(s):  
Meghit Boumediene Khaled ◽  
Nada Benajiba
Keyword(s):  
Immune System ◽  
Infectious Diseases ◽  
Nutritional Status ◽  
Infected Individual ◽  
Emerging Infectious Diseases ◽  
The Body ◽  
Healthy Diet ◽  
World Health ◽  
Viral Diseases ◽  
Prevention Measures

The immune system is involved in the protection of host against environmental agents such as pathogenic micro-organisms (bacteria, fungi, and viruses) and chemicals, thereby preserving the integrity of the body. To preserve organism defense mechanisms, adequate nutritional status should be maintained with appropriate intakes of calories, vitamins, minerals and water that should be continuously provided by a healthy diet. The emergence of new infectious diseases with new pathogenic properties constitutes a serious health issue worldwide. Severe acute respiratory syndrome (SARS) represents one of the most recent emerging infectious diseases, caused by a novel coronavirus member called (SARS-CoV-2), identified in Wuhan, Hubei, China in December 2019, and recognized as pandemic by the World Health Organization (WHO). The nutritional status of each COVID-19-infected patient should be assessed prior undertaking treatments. Nutritional support should be the basis of management of any infected individual. However, prevention measures remain the first priority and strategy to develop throughout proper hygiene, healthy diet and staying home. Keywords: Nutrition, Immune system, Viral diseases, SARS-CoV-2.

Emerging and Reemerging Infectious Diseases - Past, Present and Future

2007 ◽  
Vol 2 (2) ◽  
pp. 66-70 ◽  
Author(s):  
Yoshifumi Takeda ◽  
Keyword(s):  
Infectious Diseases ◽  
Emerging Infectious Diseases ◽  
World Health ◽  
Control Law ◽  
Global Response ◽  
The Us ◽  
The World ◽  
Us Government ◽  
Health Organization ◽  
Global Threat

The global threat of new infectious diseases first became widely recognized in the 1990s. The US government published a report on emerging and reemerging infectious diseases followed by the World Health Organization (WHO), which adopted the slogan "Emerging Infectious Diseases: Global Alert, Global Response" in 1997. Typical examples of the more than 30 infectious diseases emerging since 1970s are HIV/AIDS, Vibrio cholerae O139 infection, enterohemorrhagic Escherichia coli infection, severe acute respiratory syndrome (SARS), and avian influenza. The New Infectious Diseases Control Law enacted in Japan in 1999 was to control these emerging infectious diseases and the already existing ones.

scholarly journals Identifying the World Health Organization’s fifth moment for hand hygiene: Infection prevention in the operating room

2019 ◽  
Vol 21 (1) ◽  
pp. 28-34
Author(s):  
Fiona Smith ◽  
Karen Lee ◽  
Eleanor Binnie-McLeod ◽  
Mark Higgins ◽  
Elizabeth Irvine ◽  
...  
Keyword(s):  
Hand Hygiene ◽  
Operating Room ◽  
Direct Contact ◽  
Phase 1 ◽  
World Health ◽  
Phase 2 ◽  
Frontline Staff ◽  
The World ◽  
Hygiene Compliance ◽  
Health Organization

Background: The World Health Organization have designed the fifth of their ‘5 moments’ for hand hygiene to account for microbial transfer from patients to equipment in a narrow area around that patient, known as the patient zone. The study was prompted by emerging local confusion about application of the patient zone in the operating room (OR). Aim/Objectives: In two phases, we aimed to create a ‘5 moments’ style poster displaying an OR patient zone: phase 1, quantify equipment, in direct contact with the patient and, touched by non-scrubbed staff immediately after touching the patient; and phase 2, categorise equipment identified in phase 1 into patient zone and healthcare zone. An objective is to produce a ‘5 moments’ poster for the OR. Methods: The first phase used non-participant direct overt observation. In phase 2, phase 1 data were collaboratively assigned to patient zone or healthcare zone. Photography and graphic design were used to produce the OR ‘5 moments’ poster. Results: In 11 full-length surgeries, 20 pieces of equipment were in direct contact with the patient and 57 pieces of equipment were touched. In phase 2, a ‘5 moments’ poster showing an OR patient zone was designed. Discussion: Content of the patient zone was identified and displayed in a novel resource. Having shared understanding of the patient zone has potential to sustain hand hygiene compliance and equipment cleaning in the OR. Conclusion: Limitations in methods were balanced by collaboration with frontline staff. The study has been used as a teaching tool in the OR and similar settings.

scholarly journals A bibliometric analysis of research on Ebola in Science Citation Index Expanded

2016 ◽  
Vol Volume 112 (Number 3/4) ◽  
Author(s):  
Anastassios Pouris ◽  
Yuh-Shan Ho ◽  
◽  
Keyword(s):  
Infectious Diseases ◽  
Ebola Virus ◽  
Emerging Infectious Diseases ◽  
The United States ◽  
World Health ◽  
Global Public Health ◽  
African Countries ◽  
Citation Pattern ◽  
Global Trends ◽  
Experimental Drugs

Abstract An unprecedented outbreak of the Ebola virus in 2014 claimed more than 1000 lives in West Africa and the World Health Organization declared a global public health emergency. This outbreak will undoubtedly promote additional research related to the Ebola virus and will create debate related to experimental drugs. This article identified the quantum of research in the field since 1991; the scientific disciplines that contributed to the field; the countries, organisations and authors that supported such research and the most cited articles. An increasing trend in annual production during 1991–2013 was observed. Journal of Virology, Journal of Infectious Diseases, and Virology were the three most productive journals in the field. Similarly, the field of virology dominated the 73 categories in which the Ebola research was classified. A total of 63 countries contributed to Ebola-related research, led by the USA. The most productive institutions were the United States Army Medical Research Institute of Infectious Diseases, the Centers for Disease Control and Prevention, and the National Institute of Allergy and Infectious Diseases. African countries were more likely to be involved in international collaboration than independent research. The most influential article exhibited a notable citation pattern and presented global trends in emerging infectious diseases.

scholarly journals Emerging infectious diseases: A proactive approach

2017 ◽  
Vol 114 (16) ◽  
pp. 4055-4059 ◽  
Author(s):  
David E. Bloom ◽  
Steven Black ◽  
Rino Rappuoli
Keyword(s):  
Infectious Diseases ◽  
New Technologies ◽  
Population Aging ◽  
Rapid Development ◽  
Emerging Infectious Diseases ◽  
Point Of View ◽  
Leadership Role ◽  
World Health ◽  
Regulatory Processes ◽  
Health Organization

Infectious diseases are now emerging or reemerging almost every year. This trend will continue because a number of factors, including the increased global population, aging, travel, urbanization, and climate change, favor the emergence, evolution, and spread of new pathogens. The approach used so far for emerging infectious diseases (EIDs) does not work from the technical point of view, and it is not sustainable. However, the advent of platform technologies offers vaccine manufacturers an opportunity to develop new vaccines faster and to reduce the investment to build manufacturing facilities, in addition to allowing for the possible streamlining of regulatory processes. The new technologies also make possible the rapid development of human monoclonal antibodies that could become a potent immediate response to an emergency. So far, several proposals to approach EIDs have been made independently by scientists, the private sector, national governments, and international organizations such as the World Health Organization (WHO). While each of them has merit, there is a need for a global governance that is capable of taking a strong leadership role and making it attractive to all partners to come to the same table and to coordinate the global approach.

scholarly journals Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis

2021 ◽  
Vol 22 (7) ◽  
pp. 3773
Author(s):  
Radha Gopalaswamy ◽  
Selvakumar Subbian
Keyword(s):  
Infectious Diseases ◽  
Clinical Symptoms ◽  
Virus Disease ◽  
Clinical Signs ◽  
Significant Risk ◽  
Viral Disease ◽  
Control Measures ◽  
World Health ◽  
Global Pandemic ◽  
Health Organization

On 11 March 2020, the World Health Organization announced the Corona Virus Disease-2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), affects the respiratory system, with the clinical symptoms ranging from mild to severe or critical illness that often requires hospitalization and oxygen support. There is no specific therapy for COVID-19, as is the case for any common viral disease except drugs to reduce the viral load and alleviate the inflammatory symptoms. Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb), also primarily affects the lungs and has clinical signs similar to pulmonary SARS-CoV-2 infection. Active TB is a leading killer among infectious diseases and adds to the burden of the COVID-19 pandemic worldwide. In immunocompetent individuals, primary Mtb infection can also lead to a non-progressive, asymptomatic latency. However, latent Mtb infection (LTBI) can reactivate symptomatic TB disease upon host immune-suppressing conditions. Importantly, the diagnosis and treatment of TB are hampered and admixed with COVID-19 control measures. The US-Center for Disease Control (US-CDC) recommends using antiviral drugs, Remdesivir or corticosteroid (CST), such as dexamethasone either alone or in-combination with specific recommendations for COVID-19 patients requiring hospitalization or oxygen support. However, CSTs can cause immunosuppression, besides their anti-inflammatory properties. The altered host immunity during COVID-19, combined with CST therapy, poses a significant risk for new secondary infections and/or reactivation of existing quiescent infections, such as LTBI. This review highlights CST therapy recommendations for COVID-19, various types and mechanisms of action of CSTs, the deadly combination of two respiratory infectious diseases COVID-19 and TB. It also discusses the importance of screening for LTBI to prevent TB reactivation during corticosteroid therapy for COVID-19.

Sign in / Sign up

Export Citation Format

Share Document